Thrivent Financial for Lutherans decreased its stake in Paragon 28, Inc. (NYSE:FNA - Free Report) by 33.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 674,500 shares of the company's stock after selling 346,688 shares during the period. Thrivent Financial for Lutherans owned 0.81% of Paragon 28 worth $4,506,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in FNA. Price T Rowe Associates Inc. MD lifted its position in shares of Paragon 28 by 16.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 12,622 shares of the company's stock valued at $156,000 after buying an additional 1,766 shares during the last quarter. The Manufacturers Life Insurance Company boosted its position in Paragon 28 by 9.0% during the second quarter. The Manufacturers Life Insurance Company now owns 25,992 shares of the company's stock worth $178,000 after purchasing an additional 2,142 shares during the period. Rhumbline Advisers increased its holdings in shares of Paragon 28 by 6.0% in the second quarter. Rhumbline Advisers now owns 65,727 shares of the company's stock valued at $450,000 after purchasing an additional 3,720 shares during the last quarter. Algert Global LLC raised its position in shares of Paragon 28 by 12.0% in the second quarter. Algert Global LLC now owns 38,793 shares of the company's stock valued at $265,000 after purchasing an additional 4,157 shares during the period. Finally, Nisa Investment Advisors LLC lifted its stake in shares of Paragon 28 by 46,660.0% during the 2nd quarter. Nisa Investment Advisors LLC now owns 4,676 shares of the company's stock worth $32,000 after buying an additional 4,666 shares during the last quarter. Institutional investors and hedge funds own 63.57% of the company's stock.
Analyst Ratings Changes
Several research analysts have weighed in on the stock. Needham & Company LLC increased their price target on shares of Paragon 28 from $11.00 to $13.00 and gave the company a "buy" rating in a report on Wednesday, November 13th. Piper Sandler restated an "overweight" rating and issued a $12.00 price target (down from $15.00) on shares of Paragon 28 in a research note on Friday, August 9th. Finally, Canaccord Genuity Group decreased their price objective on Paragon 28 from $17.00 to $15.00 and set a "buy" rating on the stock in a report on Wednesday, November 13th. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average price target of $15.60.
Check Out Our Latest Stock Analysis on Paragon 28
Insider Buying and Selling at Paragon 28
In other news, major shareholder Mvm Partners, Llc sold 147,581 shares of the stock in a transaction dated Wednesday, November 20th. The shares were sold at an average price of $10.28, for a total value of $1,517,132.68. Following the completion of the transaction, the insider now owns 10,738,564 shares of the company's stock, valued at approximately $110,392,437.92. This represents a 1.36 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 15.32% of the company's stock.
Paragon 28 Trading Down 1.7 %
Paragon 28 stock traded down $0.17 during mid-day trading on Monday, reaching $9.87. 808,048 shares of the company were exchanged, compared to its average volume of 614,934. The company has a debt-to-equity ratio of 0.79, a current ratio of 3.50 and a quick ratio of 1.60. The company has a fifty day simple moving average of $6.71 and a 200-day simple moving average of $7.21. Paragon 28, Inc. has a 12 month low of $4.65 and a 12 month high of $14.79.
Paragon 28 (NYSE:FNA - Get Free Report) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($0.15) EPS for the quarter, topping analysts' consensus estimates of ($0.16) by $0.01. Paragon 28 had a negative return on equity of 37.90% and a negative net margin of 25.31%. The company had revenue of $62.30 million for the quarter, compared to analysts' expectations of $60.58 million. During the same quarter last year, the business earned ($0.10) earnings per share. Paragon 28's revenue was up 18.0% on a year-over-year basis. As a group, equities analysts anticipate that Paragon 28, Inc. will post -0.66 EPS for the current year.
Paragon 28 Company Profile
(
Free Report)
Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.
Recommended Stories
Before you consider Paragon 28, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Paragon 28 wasn't on the list.
While Paragon 28 currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.